- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Breast Cancer in South Africa
Total 924 results
-
PfizerTerminatedAdvanced CancerItaly, United States, Canada, Spain
-
SCRI Development Innovations, LLCEisai Inc.CompletedMetastatic Breast CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
International Agency for Research on CancerBarretos Cancer Hospital; Instituto Nacional de Salud Publica, Mexico; University... and other collaboratorsRecruitingBreast Cancer FemaleChile, Colombia, Brazil, Costa Rica, Mexico
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel, Spain, Australia, Canada, New Zealand, United Kingdom, France, Tunisia
-
Eli Lilly and CompanyCompleted
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast CancerUnited States, South Africa, Canada, Argentina, Chile, Bulgaria, Croatia, Netherlands, Estonia, Denmark, Poland, Brazil, Mexico, Romania
-
Konica Minolta Medical Imaging, USACompletedBreast CancerUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Case Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingStage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
University of SydneyCompletedBreast CancerAustralia
-
Hoosier Cancer Research NetworkPurdue University; Indiana University School of MedicineCompletedBreast CancerUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Elevation OncologyActive, not recruitingSarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bladder Cancer | Metastatic Solid Tumor | Gallbladder Cancer | Uterine Cancer | Locally Advanced Solid TumorUnited States, Korea, Republic of, Australia, Canada
-
SCRI Development Innovations, LLCSanofiCompleted
-
Novartis PharmaceuticalsTerminated
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
ImmunityBio, Inc.CompletedMetastatic, Locally Advanced or Unresectable Soft Tissue SarcomaUnited States, Spain, Denmark, Israel, Canada, Australia, Hungary, Chile, France, Italy, Netherlands, Poland, Russian Federation
-
Novartis PharmaceuticalsCompletedBreast CancerSaudi Arabia, Argentina, Belgium, Spain, Italy, Korea, Republic of, South Africa, France, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Urothelial Carcinoma | Recurrent Urothelial Carcinoma | Unresectable Urothelial Carcinoma | Advanced Urothelial CarcinomaUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Fusion Pharmaceuticals Inc.RecruitingCervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial Cancer | Uveal Melanoma | Adrenocortical Carcinoma | Advanced Solid Tumours | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC)United States, Australia, Canada
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
Alaunos TherapeuticsCompletedBreast Cancer Nos Metastatic RecurrentUnited States
-
SCRI Development Innovations, LLCEisai Inc.CompletedHER2 Negative Breast CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer InstituteTerminated
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage...United States, South Africa
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
AstraZenecaCompletedBreast CancerUnited States, South Africa, Spain, France, Netherlands, United Kingdom, Greece, Canada
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Genentech, Inc.No longer availableMetastatic Breast CancerUnited States
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
PfizerTerminated
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced CancerSpain, Argentina, United States, Korea, Republic of, Taiwan, Belgium, Romania, Germany, United Kingdom, Australia, Brazil, Canada, China, Czechia, Denmark, France, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Mexico, Netherlands, ... and more
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerBelgium, France, Netherlands, United States, Spain
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); United States Department of Defense and other collaboratorsRecruitingBreast Cancer | Breast Cancer Screening | Breast Carcinoma in SituUnited States